Journals / Acta Medica / 2022 / Cilt: 53 - Sayı: 2

Biliary Tract Disorders in Patients with Acromegaly: Single-centre Experience

Pages
180–187
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Body mass index (β=1.19, 95% CI (1.09-1.30), p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Genetic and environmental factors determine the risk of biliary tract disorders.
📊
Key Findings & Data:Several studies have reported an increased frequency of gallbladder disorders in patients with acromegaly belonging to different ethnic groups, however, data for Turkish patients with acromegaly is currently lacking.
💡
Conclusion & Impact:Body mass index (β=1.19, 95% CI (1.09-1.30), p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Genetic and environmental factors determine the risk of biliary tract disorders. Several studies have reported an increased frequency of gallbladder disorders in patients with acromegaly belonging to different ethnic groups, however, data for Turkish patients with acromegaly is currently lacking. The primary objective of this study was to evaluate the frequency of diverse gallbladder disorders in Turkish patients with acromegaly. The secondary objective was to determine the risk factors that are related to gallstone formation. Materials and Methods: Hacettepe University electronic database was retrospectively analyzed. One hundred fifty-two out of 393 patients with acromegaly who had confirmed biliary tract disorders with imaging modalities (such as abdominal ultrasonography, abdominal computed tomography or abdominal magnetic resonance imaging) or surgery specimens, were included for final analyzes. There was not any difference between included and excluded cases in terms of study parameters. Results: Patients with acromegaly with a mean±SD age of 41±12 years were followed-up for median of 91 months. Gender distribution was equal (76 M, 76 F). Gallstones were detected in 50 (33%) cases. Seventeen (11%) cases had gallbladder sludge whereas 5 (3%) cases had gallbladder polyp. Cholecystectomy was performed in 24 (16%). Age, gender, baseline disease activity, diagnostic delay, disease duration, the presence of type 2 diabetes mellitus and hyperlipidemia were not associated with gallstone formation. Body mass index (β=1.19, 95% CI (1.09-1.30), p

🔖

Cite This Article

ŞENDUR, S. N., OĞUZ, S. H. (2022). Biliary Tract Disorders in Patients with Acromegaly: Single-centre Experience. Acta Medica, Cilt: 53 - Sayı: 2, 180–187. https://ajindex.com/articles/427523

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Katznelson L, Laws ER, Jr., Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism 2014
  2. 99(11):3933- 51. doi: 10.1210/jc.2014-2700 [2] Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine reviews 2004
  3. 25(1):102-52. doi: 10.1210/er.2002-0022 [3] Renehan AG, Painter JE, Bell GD, Rowland RS, O’Dwyer ST, Shalet SM. Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy. Clinical endocrinology 2005
  4. 62(3):323-30. doi: 10.1111/j.1365-2265.2005.02217.x [4] Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World journal of gastroenterology 2008
  5. 14(22):3484-9. doi: 10.3748/ wjg.14.3484 [5] Wassenaar MJ, Cazemier M, Biermasz NR, et al. Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. The Journal of clinical endocrinology and metabolism 2010
  6. 95(5):2073-9. doi: 10.1210/jc.2009-1714 [6] Baris D, Gridley G, Ron E, et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer causes & control: CCC 2002
  7. 13(5):395-400. doi: 10.1023/a:1015713732717 [7] Annamalai AK, Gayton EL, Webb A, et al. Increased prevalence of gallbladder polyps in acromegaly. The Journal of clinical endocrinology and metabolism 2011
  8. 96(7):E1120-5. doi: 10.1210/jc.2010-2669 [8] Aapkes SE, de Haas RJ, Bernts LHP, et al. Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation. Drugs in R&D 2021
  9. 21(2):179-88. doi: 10.1007/s40268-021-00342-7 [9] Grasso LF, Auriemma RS, Pivonello R, Colao A. Adverse events associated with somatostatin analogs in acromegaly. Expert opinion on drug safety 2015
  10. 14(8):1213-26. doi: 10.1517/14740338.2015.1059817 [10] Prencipe N, Bona C, Cuboni D, et al. Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment. Pituitary 2021
  11. 24(2):242-51. doi: 10.1007/ s11102-020-01102-7 [11] Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nature reviews. Disease primers 2016
  12. 16024. doi: 10.1038/ nrdp.2016.24 [12] Aerts R, Penninckx F. The burden of gallstone disease in Europe. Alimentary pharmacology & therapeutics 2003
  13. 18 Suppl 3:49-53. doi: 10.1046/